5 ML isatuximab-irfc 20 MG/ML Injection

RxCUI: 2282023
RxNorm name: 5 ML isatuximab-irfc 20 MG/ML Injection
Display name: 5 ML isatuximab-irfc 20 MG/ML Injection
Full name: 5 ML isatuximab-irfc 20 MG/ML Injection
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:11

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761113	Sarclisa	isatuximab-irfc	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Sarclisa	ISATUXIMAB	Sanofi-Aventis U.S. LLC	a0473462-6f9d-4eca-a5bf-8620aea68e8a	2026-07-07	Warnings, Adverse reactions	Exact identifier rxcui: 2282023

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
a0473462-6f9d-4eca-a5bf-8620aea68e8a	5 ML isatuximab-irfc 20 MG/ML Injection	SCD	17	These highlights do not include all the information needed to use SARCLISA safely and effectively. See full prescribing information for SARCLISA. SARCLISA ® (isatuximab-irfc) injection, for intravenous use Initial U.S. Approval: 2020	20250616
a0473462-6f9d-4eca-a5bf-8620aea68e8a	isatuximab-irfc 100 MG in 5 ML Injection	PSN	17	These highlights do not include all the information needed to use SARCLISA safely and effectively. See full prescribing information for SARCLISA. SARCLISA ® (isatuximab-irfc) injection, for intravenous use Initial U.S. Approval: 2020	20250616
a0473462-6f9d-4eca-a5bf-8620aea68e8a	isatuximab-irfc 100 MG per 5 ML Injection	SY	17	These highlights do not include all the information needed to use SARCLISA safely and effectively. See full prescribing information for SARCLISA. SARCLISA ® (isatuximab-irfc) injection, for intravenous use Initial U.S. Approval: 2020	20250616